Initial Therapeutics
Biotechnology company creating novel drugs that prevent the formation of difficult-to-drug proteins, targeting protein homeostasis with a cotranslational degradation approach.
Location
Cambridge, Massachusetts, USA
Founded
2021
Investors
1
Categories
biotech, drug-discovery, protein-homeostasis, undruggable-targets
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| Apple Tree Partners | New York, USA | biotech-focused | series-aseries-b+2 | 23 |
